Similar articles for PMID: 19910417

Year	Number of Results
1987	1
1988	1
1990	1
1992	2
1993	1
1995	1
1996	2
1997	4
1998	6
1999	8
2000	7
2001	4
2003	11
2004	8
2005	9
2006	4
2007	2
2009	8
2010	4
2011	4
2012	2
2013	4
2014	1
2015	2
2016	4
2017	3
2018	3
2019	3
2020	2
2021	3
2022	2
2024	0

1

Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.

Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pèlegrin M, Navarro-Teulon I, Pèlegrin A, Pouget JP. Santoro L, et al. J Nucl Med. 2009 Dec;50(12):2033-41. doi: 10.2967/jnumed.109.066993. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910417 Free PMC article.

2

Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.

Boudousq V, Ricaud S, Garambois V, Bascoul-Mollevi C, Boutaleb S, Busson M, Quenet F, Colombo PE, Bardiès M, Kotzki PO, Navarro-Teulon I, Pèlegrin A, Pouget JP. Boudousq V, et al. J Nucl Med. 2010 Nov;51(11):1748-55. doi: 10.2967/jnumed.110.080226. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956481 Free PMC article.

3

Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.

Boudousq V, Bobyk L, Busson M, Garambois V, Jarlier M, Charalambatou P, Pèlegrin A, Paillas S, Chouin N, Quenet F, Maquaire P, Torgue J, Navarro-Teulon I, Pouget JP. Boudousq V, et al. PLoS One. 2013 Jul 29;8(7):e69613. doi: 10.1371/journal.pone.0069613. Print 2013. PLoS One. 2013. PMID: 23922757 Free PMC article.

4

Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.

Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W. Behr TM, et al. Int J Cancer. 1998 May 29;76(5):738-48. doi: 10.1002/(sici)1097-0215(19980529)76:5<738::aid-ijc20>3.0.co;2-z. Int J Cancer. 1998. PMID: 9610734 Free article.

5

Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.

Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. Behr TM, et al. Eur J Nucl Med. 2000 Jul;27(7):753-65. doi: 10.1007/s002590000272. Eur J Nucl Med. 2000. PMID: 10952487

6

Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.

Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L. Elgqvist J, et al. J Nucl Med. 2005 Nov;46(11):1907-15. J Nucl Med. 2005. PMID: 16269606 Free article.

7

Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.

Koppe MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJ, Boerman OC. Koppe MJ, et al. J Nucl Med. 2004 Jul;45(7):1224-32. J Nucl Med. 2004. PMID: 15235070 Free article.

8

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.

Rondon A, Schmitt S, Briat A, Ty N, Maigne L, Quintana M, Membreno R, Zeglis BM, Navarro-Teulon I, Pouget JP, Chezal JM, Miot-Noirault E, Moreau E, Degoul F. Rondon A, et al. Theranostics. 2019 Sep 19;9(22):6706-6718. doi: 10.7150/thno.35461. eCollection 2019. Theranostics. 2019. PMID: 31588245 Free PMC article.

9

Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin.

Koppe MJ, Soede AC, Pels W, Oyen WJ, Goldenberg DM, Bleichrodt RP, Boerman OC. Koppe MJ, et al. Int J Cancer. 2003 Oct 10;106(6):965-72. doi: 10.1002/ijc.11304. Int J Cancer. 2003. PMID: 12918078 Free article.

10

Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.

Smith-Jones PM, Vallabhajosula S, Navarro V, Bastidas D, Goldsmith SJ, Bander NH. Smith-Jones PM, et al. J Nucl Med. 2003 Apr;44(4):610-7. J Nucl Med. 2003. PMID: 12679407 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

109 results

Results by year